Impact of interleukin 28B rs12979860 C/T polymorphism on severity of disease and response to treatment in hepatitis delta | Zendy

Murat İspiroğlu | Zendy; Ibrahim Halil Bahçecıoğlu | Zendy; Ulvi Demirel | Zendy; Mehmet Yalnız | Zendy

Open Access

Impact of interleukin 28B rs12979860 C/T polymorphism on severity of disease and response to treatment in hepatitis delta

Author(s) -

Murat İspiroğlu,

Ibrahim Halil Bahçecıoğlu,

Ulvi Demirel,

Mehmet Yalnız

Publication year - 2017

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.6872

Subject(s) - medicine , gastroenterology , hbsag , genotype , pegylated interferon , liver biopsy , hepatitis d virus , immunology , hepatitis b virus , chronic hepatitis , virus , biopsy , biology , ribavirin , gene , biochemistry

Pegylated-interferon alpha (Peg-IFN α) is the therapy most commonly used to treat chronic hepatitis delta virus (HDV) infection. In the present study, we planned to investigate effect of IL28B polymorphism on response to Peg-IFN α therapy and disease progression in patients with chronic HDV.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research